Fix MS Now's Blog

Home » Multiple Sclerosis » MS Awareness » Relapsing Multiple Sclerosis Patients Can Look to Second Oral Agent

Relapsing Multiple Sclerosis Patients Can Look to Second Oral Agent

The recent approval of Aubagio (teriflunomide) provides an opportunity to conduct head-to-head trials in this expanding treatment category

Have you found the drug side effects to sometimes be worse than the MS symptoms we are trying to prevent?

Relapsing Multiple Sclerosis Patients Can Look to Second Oral Agent http://managedcaremag.com/archives/1302/1302.biotech.html#.UUNTdiNGtjx.twitterRelapsing Multiple Sclerosis Patients Can Look to Second Oral Agent

20130315-130342.jpg

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Follow on Twitter

Error: Twitter did not respond. Please wait a few minutes and refresh this page.

Past Posts:

%d bloggers like this: